{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:07:15Z","timestamp":1795090035185,"version":"4.10.2"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Rheumatoid arthritis (RA) is a chronic debilitating inflammatory disease affecting mainly the joint, surrounding tissue and other extra-articular structures in the body. RA can lead to destruction of bone and cartilage which may cause severe disability and it is characterized by the presence of serum rheumatoid factor (RF). The anti-cyclic citrullinate peptide (anti-CCP) antibody is another serum biomarker used in RA diagnosis with higher sensitivity and specificity.<\/jats:p>\n            <jats:p>In this cross-sectional study with retrospective record review, 159 established RA patients from Hospital Universiti Sains Malaysia (HUSM) were recruited. Enzyme-linked immunosorbent assays (ELISAs) for serum RF and anti-CCP were performed. Our goal was to evaluate the significance of anti-CCP antibody in predicting the disease activity and progression in terms of radiological and extra-articular manifestations upon diagnosis.<\/jats:p>\n            <jats:p>Of the 159 RA patients included in this study, mean age was 48.3 years old and majority (n\u200a=\u200a134; 84.3%) were female. A total of 83 (52.2%) and 99 (62.3%) patients had anti-CCP antibody and RF, respectively. Mean Disease Activity Score-28 for Rheumatoid Arthritis with erythrocyte sedimentation rate (ESR) (DAS28-ESR) score for all patients was 4.74 (medium and high disease activity). Fifty-eight (36.5%) patients had radiological defects and 49 (30.8%) patients had extra-articular involvement manifested by rheumatoid nodule, pulmonary involvement, and anemia.<\/jats:p>\n            <jats:p>In terms of anti-CCP antibody association with clinical and laboratory parameters, a significant co-occurrence of RF and anti-CCP antibody (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.002) was observed. Anti-CCP antibody was significantly associated with radiological defects in which majority of patients with such defects (n\u200a=\u200a40\/58; 68.9%) were positive for anti-CCP antibody (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001). However, there was no significant difference between mean and classes of disease activity score and extra-articular manifestations between different anti-CCP antibody groups. In addition, extra-articular manifestations were not associated with high disease activity upon RA diagnosis<\/jats:p>\n            <jats:p>There was a significant association between anti-CCP antibody positivity and positive RF. Radiological defects were the sole clinical parameter significantly associated with anti-CCP antibody positivity, indicating that patients positive for anti-CCP antibody should be routinely monitored for radiological defects and their onset.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014945","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T11:50:14Z","timestamp":1553169014000},"page":"e14945","source":"Crossref","is-referenced-by-count":18,"title":["Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients"],"prefix":"10.1097","volume":"98","author":[{"given":"Farah Nadiah","family":"Sulaiman","sequence":"first","affiliation":[{"name":"Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Keng","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Aireene Wan","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Radiology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Syamimee Wan","family":"Ghazali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun Rev"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/qjmed\/hcm015","article-title":"Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis","volume":"100","author":"Niewold","year":"2007","journal-title":"QJM"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-007-8022-5","article-title":"Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?","volume":"34","author":"Szekanecz","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.62.9.870","article-title":"Clinical utility of the anti-CCP assay in patients with rheumatic diseases","volume":"62","author":"Lee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R6-20230914","first-page":"147","article-title":"Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity","volume":"13","author":"Shakiba","year":"2014","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"R7-20230914","first-page":"21","article-title":"Relationship between anti-cyclic citrullinated peptide antibodies and disease activity and extra-articular manifestations of rheumatoid arthritis in Egyptian patients","volume":"9","author":"Eltokhy","year":"2011","journal-title":"Al-Azhar Assiut Med J"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MD.0b013e318289ce01","article-title":"Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients","volume":"92","author":"Richman","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"R9-20230914","first-page":"53","volume":"3","author":"Kalappan","year":"2016","journal-title":"Study of extra-articular manifestations and disease severity in patients with rheumatoid arthritis"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1756-185X.2009.01412.x","article-title":"Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity","volume":"12","author":"Sockalingam","year":"2009","journal-title":"Int J Rheum Dis"},{"key":"R11-20230914","first-page":"773","article-title":"Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis","volume":"29","author":"Abdul Wahab","year":"2013","journal-title":"Pak J Med Sci"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/117727190700200007","article-title":"The clinical application of anti-CCP in rheumatoid arthritis and other rheumatic diseases","volume":"2","author":"Chou","year":"2007","journal-title":"Biomark Insights"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.62.5.427","article-title":"Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis","volume":"62","author":"Vencovsky","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2003.008623","article-title":"Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases","volume":"63","author":"Dubucquoi","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/rheumatology\/keg184","article-title":"Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis","volume":"42","author":"Bas","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-008-0570-3","article-title":"The association of anti-CCP antibodies with disease activity in rheumatoid arthritis","volume":"28","author":"Serdaroglu","year":"2008","journal-title":"Rheumatol Int"},{"key":"R17-20230914","first-page":"281","article-title":"Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness","volume":"24","author":"del Val del Amo","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","article-title":"Use and significance of anti-CCP autoantibodies in rheumatoid arthritis","volume":"45","author":"Zendman","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","article-title":"Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)","volume":"63","author":"Kastbom","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","article-title":"Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage","volume":"62","author":"Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","article-title":"Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)","volume":"63","author":"Forslind","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1755-7682-1-20","article-title":"Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis","volume":"1","author":"Fathi","year":"2008","journal-title":"Int Arch Med"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s13075-014-0448-6","article-title":"Diagnostic utility of musculoskeletal ultrasound in patients with suspected arthritis \u2013 a probabilistic approach","volume":"16","author":"Hamed","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/PL00006853","article-title":"Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis","volume":"19","author":"Cimmino","year":"2000","journal-title":"Rheumatol Int"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.clinbiochem.2006.06.004","article-title":"Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations","volume":"39","author":"Korkmaz","year":"2006","journal-title":"Clin Biochem"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/ard.2006.052803","article-title":"Multiple extra-articular manifestations are associated with poor survival in patients with rheumatoid arthritis","volume":"65","author":"Turesson","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R28-20230914","first-page":"286","article-title":"Extra-articular manifestations in rheumatoid arthritis","volume":"5","author":"Cojocaru","year":"2010","journal-title":"Maedica (Buchar)"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00296-006-0133-4","article-title":"Anemia in rheumatoid arthritis: high prevalence of iron-deficiency anemia in Indian patients","volume":"26","author":"Agrawal","year":"2006","journal-title":"Rheumatol Int"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5152\/eurjrheumatol.2014.022","article-title":"The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: a comparative study","volume":"1","author":"Eker","year":"2014","journal-title":"Eur J Rheumatol"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"103","DOI":"10.33590\/emjrheumatol\/10312044","article-title":"Extra-articular manifestations of rheumatoid arthritis, now","volume":"1","author":"Vela","year":"2014","journal-title":"EMJ Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201903220-00052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:19:32Z","timestamp":1694719172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201903220-00052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014945","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}